Aclaris Therapts (ACRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -132,065 | -88,481 | -86,908 | -90,865 | -51,015 |
| Depreciation Amortization | 807 | 863 | 797 | 923 | 1,324 |
| Income taxes - deferred | N/A | -367 | N/A | N/A | -182 |
| Accounts receivable | -20 | 186 | 139 | 149 | 4,898 |
| Accounts payable and accrued liabilities | -4,188 | -1,473 | 368 | 3,655 | -5,219 |
| Other Working Capital | 10,922 | 9,389 | -1,195 | -1,343 | -2,360 |
| Other Operating Activity | 104,469 | 1,558 | 19,232 | 35,347 | 13,921 |
| Operating Cash Flow | $-20,075 | $-78,325 | $-67,567 | $-52,134 | $-38,633 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -121 | -1,309 | -605 | -308 | -453 |
| Purchase Of Investment | -119,982 | -135,675 | -164,753 | -235,153 | -47,714 |
| Sale Of Investment | 86,144 | 183,204 | 177,986 | 67,829 | 54,554 |
| Purchase Sale Intangibles | -35,810 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -35,810 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-69,769 | $46,220 | $12,628 | $-167,632 | $6,387 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | -11,483 | -137 |
| Common Stock Issued | 74,945 | 26,808 | 72,901 | 239,659 | 7,807 |
| Other Financing Activity | -409 | -102 | -34 | -3,124 | 10,702 |
| Financing Cash Flow | $74,536 | $26,706 | $72,867 | $225,052 | $18,372 |
| Beginning Cash Position | 39,878 | 45,277 | 27,349 | 22,063 | 35,937 |
| End Cash Position | 24,570 | 39,878 | 45,277 | 27,349 | 22,063 |
| Net Cash Flow | $-15,308 | $-5,399 | $17,928 | $5,286 | $-13,874 |
| Free Cash Flow | |||||
| Operating Cash Flow | -20,075 | -78,325 | -67,567 | -52,134 | -38,633 |
| Capital Expenditure | -121 | -1,309 | -605 | -308 | -453 |
| Free Cash Flow | -20,196 | -79,634 | -68,172 | -52,442 | -39,086 |